Dr. NK Arora, Chairman of the NTAGI Covid-19 Working Group, stated on Tuesday (February 15) that the Covid-19 vaccine Corbevax is a safe vaccine that will be administered in two doses like other vaccines.
“Corbevax is a safe vaccine and local reactions are also less. The antibody level of this vaccine is also very high. Overall Corbevax is a very useful vaccine. It will have 2 primary doses just like other vaccines in India,” told Dr Arora to ANI.
This comes after India`s apex drug regulatory body Drugs Controller General of India`s Subject Expert Committee on Monday (February 14) granted the restricted emergency use authorisation to Biological E`s Covid vaccine Corbevax for adolescents in the 12 to 18 years age bracket. However, the approval is subject to certain conditions, said a source familiar with the development.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…